Peptone is a Molecular Computational Physics company that is focusing on bringing to the market an AI-orchestrated operating system for completely automated protein drug engineering. Our Protein Engineering Operating System (PeOS) will handle a variety of mundane and complex tasks that are related to anomaly detection, risk of failure calculation and suggest the most plausible routes of failure resolution, including choosing the right commercial partner to generate lab-quality molecule at a pace and cost not attainable before in the Big Pharma sector.
Location: United Kingdom, England, London
Employees: 11-50
Total raised: $42.5M
Founded date: 2018
Investors 3
| Date | Name | Website |
| 11.06.2022 | Bessemer V... | bvp.com |
| - | dRx Capita... | drxcapital... |
| 23.06.2024 | dRx Capita... | live-drxca... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 14.06.2022 | - | $40M | - |
| 08.01.2021 | Seed | $2.5M | - |
Mentions in press and media 6
| Date | Title | Description |
| 14.06.2022 | London-based Peptone raises €38.29M to help discover drugs for tricky ‘disordered’ proteins | London-based Peptone, a startup that helps pharmaceutical companies unravel the secrets of proteins, announced that it has raised $40M (approximately €38.29M) in its Series A round of funding. The round was led by F-Prime Capital and Bessem... |
| 09.06.2022 | Peptone, a startup using A.I. to find drugs for tricky ‘disordered’ proteins, raises $40 million in venture funding | Sign up for the Fortune Features email list so you don’t miss our biggest features, exclusive interviews, and investigations. Peptone, a London-based startup that is using artificial intelligence and advanced atomic imaging techniques to pu... |
| 09.06.2022 | London startup Peptone gets $40-million booster to focus on drugs for disordered proteins | Around half the proteins in the human body, including many that are crucial in health and disease, have some regions that do not fold neatly into fixed structures and thus cannot be accurately predicted from the underlying genetic sequences... |
| 08.01.2021 | UK biotech startup Peptone grabs £1.84M to make drug discovery faster and more effective with AI | The global COVID-19 pandemic has unveiled a grave issue – the requirement to develop efficient drugs quickly. 2020 has been a tough year that has seen scientists heralded as heroes and the future of protein-based medicine has sat at the coa... |
| 08.01.2021 | London-based Peptone nabs €2 million to help big pharma develop life-saving proteins | Peptone, a computational physics company that has built one of the world’s first protein engineering operating systems, has landed an approx. €2 million seed round. The round was led by Hoxton Ventures and supported by dRx Capital, a ventur... |
| - | London startup Peptone gets $40-million booster to focus on drugs for disordered proteins | Around half the proteins in the human body, including many that are crucial in health and disease, have some regions that do not fold neatly into fixed structures and thus cannot be accurately predicted from the underlying genetic sequences... |